{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:18:19Z","timestamp":1783570699577,"version":"3.55.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"crossref","award":["43014302"],"award-info":[{"award-number":["43014302"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06049-4","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T10:54:18Z","timestamp":1781348058000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sex-stratified polygenic risk scores for coronary artery disease incidence: Insights from a 20-year cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Leila","family":"Najd-Hassan-Bonab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Moazzam-Jazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Mahdavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1525-8672","authenticated-orcid":false,"given":"Maryam S.","family":"Daneshpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"6049_CR1","doi-asserted-by":"publisher","unstructured":"Stark B, Johnson C, Roth GA. Global prevalence of coronary artery disease:an update from the global burden of disease study. J Am Coll Cardiol. 2024;83:2320.https:\/\/doi.org\/10.1016\/s0735-1097(24)04310-9.","DOI":"10.1016\/s0735-1097(24)04310-9"},{"key":"6049_CR2","doi-asserted-by":"publisher","unstructured":"Huang Y, Hui Q, Gwinn M, et al. Sexual Differences in Genetic Predisposition of Coronary Artery Disease. Circ Genomic Precis Med. 2021;14:E003147. https:\/\/doi.org\/10.1161\/CIRCGEN.120.003147.","DOI":"10.1161\/CIRCGEN.120.003147"},{"key":"6049_CR3","doi-asserted-by":"crossref","unstructured":"Yahagi K, Davis HR, Arbustini E, Virmani R. Sex differences in coronary artery disease: Pathological observations. Atherosclerosis. 2015;239:260\u2013267","DOI":"10.1016\/j.atherosclerosis.2015.01.017"},{"key":"6049_CR4","doi-asserted-by":"publisher","unstructured":"Mosca L, Barrett-Connor E, Kass Wenger N. Sex\/gender differences in cardiovascular disease prevention: What a difference a decade makes. Circulation.2011;124:2145\u20132154. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.968792.","DOI":"10.1161\/CIRCULATIONAHA.110.968792"},{"key":"6049_CR5","doi-asserted-by":"publisher","unstructured":"Vaccarino V, Horwitz RI, Meehan TP, et al. Sex differences in mortality after myocardial infarction: Evidence for a sex-age interaction. Arch Intern Med. 1998;58:2054\u20132062. https:\/\/doi.org\/10.1001\/archinte.158.18.2054.","DOI":"10.1001\/archinte.158.18.2054"},{"key":"6049_CR6","doi-asserted-by":"publisher","unstructured":"Nikpay M, Goel A, Won HH, et al. A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet. 2015;47:1121\u20131130. https:\/\/doi.org\/10.1038\/ng.3396.","DOI":"10.1038\/ng.3396"},{"key":"6049_CR7","doi-asserted-by":"publisher","unstructured":"Buniello A, Macarthur JAL, Cerezo M, et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 2019;47:D1005\u2013D1012. https:\/\/doi.org\/10.1093\/nar\/gky1120.","DOI":"10.1093\/nar\/gky1120"},{"key":"6049_CR8","doi-asserted-by":"publisher","unstructured":"Mosley JD, Gupta DK, Tan J, et al. Predictive Accuracy of a Polygenic Risk Score Compared with a Clinical Risk Score for Incident Coronary Heart Disease. JAMA - J Am Med Assoc. 2020;323:627\u2013635. https:\/\/doi.org\/10.1001\/jama.2019.21782.","DOI":"10.1001\/jama.2019.21782"},{"key":"6049_CR9","doi-asserted-by":"publisher","unstructured":"Agbaedeng TA, Noubiap JJ, Mofo Mato EP, et al. Polygenic risk score and coronary artery disease: A meta-analysis of 979,286 participant data. Atherosclerosis. 2021;333:48\u201355. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.08.020.","DOI":"10.1016\/j.atherosclerosis.2021.08.020"},{"key":"6049_CR10","doi-asserted-by":"crossref","unstructured":"Khera A V., Chaffin M, Aragam KG, et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat. Genet. 2018;50:1219\u20131224","DOI":"10.1038\/s41588-018-0183-z"},{"key":"6049_CR11","doi-asserted-by":"publisher","unstructured":"Inouye M, Abraham G, Nelson CP, et al. Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention. J Am Coll Cardiol.2018;72:1883\u20131893. https:\/\/doi.org\/10.1016\/j.jacc.2018.07.079.","DOI":"10.1016\/j.jacc.2018.07.079"},{"key":"6049_CR12","doi-asserted-by":"publisher","unstructured":"Elliott J, Bodinier B, Bond TA, et al. Predictive Accuracy of a Polygenic Risk Score-Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease. JAMA - J Am Med Assoc. 2020;323:636\u2013645. https:\/\/doi.org\/10.1001\/jama.2019.22241.","DOI":"10.1001\/jama.2019.22241"},{"key":"6049_CR13","doi-asserted-by":"publisher","unstructured":"Khan SS, Post WS, Guo X, et al. Coronary Artery Calcium Score and Polygenic Risk Score for the Prediction of Coronary Heart Disease Events. JAMA. 2023;329:1768\u20131777. https:\/\/doi.org\/10.1001\/jama.2023.7575.","DOI":"10.1001\/jama.2023.7575"},{"key":"6049_CR14","doi-asserted-by":"publisher","unstructured":"Marston NA, Pirruccello JP, Melloni GEM, et al. Predictive Utility of a Coronary Artery Disease Polygenic Risk Score in Primary Prevention. JAMA Cardiol. 2023;8:130\u2013137. https:\/\/doi.org\/10.1001\/jamacardio.2022.4466.","DOI":"10.1001\/jamacardio.2022.4466"},{"key":"6049_CR15","doi-asserted-by":"publisher","unstructured":"Riveros-Mckay F, Weale ME, Moore R, et al. Integrated Polygenic Tool Substantially Enhances Coronary Artery Disease Prediction. Circ Genomic Precis Med. 2021;14:E003304. https:\/\/doi.org\/10.1161\/CIRCGEN.120.003304","DOI":"10.1161\/CIRCGEN.120.003304"},{"key":"6049_CR16","doi-asserted-by":"publisher","unstructured":"Patel AP, Wang M, Ruan Y, et al. A multi-ancestry polygenic risk score improves risk prediction for coronary artery disease. Nat Med. 2023;29:1793\u20131803. https:\/\/doi.org\/10.1038\/s41591-023-02429-x.","DOI":"10.1038\/s41591-023-02429-x"},{"key":"6049_CR17","doi-asserted-by":"publisher","unstructured":"Zhang C, Ye Y, Zhao H. Comparison of Methods Utilizing Sex-Specific PRSs Derived From GWAS Summary Statistics. Front Genet. 2022;13:892950. https:\/\/doi.org\/10.3389\/fgene.2022.892950","DOI":"10.3389\/fgene.2022.892950"},{"key":"6049_CR18","doi-asserted-by":"publisher","unstructured":"Roberts MR, Sordillo JE, Kraft P, Asgari MM. Sex-Stratified Polygenic Risk Score Identifies Individuals at Increased Risk of Basal Cell Carcinoma. J Invest Dermatol. 2020;140:971\u2013975. https:\/\/doi.org\/10.1016\/j.jid.2019.09.020.","DOI":"10.1016\/j.jid.2019.09.020"},{"key":"6049_CR19","doi-asserted-by":"publisher","unstructured":"Flynn E, Tanigawa Y, Rodriguez F, et al. Sex-specific genetic effects across biomarkers. Eur J Hum Genet. 2021;29:154\u2013163. https:\/\/doi.org\/10.1038\/s41431-020-00712-w","DOI":"10.1038\/s41431-020-00712-w"},{"key":"6049_CR20","doi-asserted-by":"publisher","unstructured":"Najd Hassan Bonab L, Moazzam-Jazi M, Miri Moosavi RS, et al. Low HDL concentration in rs2048327-G carriers can predispose men to develop coronary heart disease: Tehran Cardiometabolic genetic study (TCGS). Gene. 2021;778:. https:\/\/doi.org\/10.1016\/j.gene.2021.145485.","DOI":"10.1016\/j.gene.2021.145485"},{"key":"6049_CR21","doi-asserted-by":"publisher","unstructured":"Najd-Hassan-Bonab L, Givi NJ, Moazzam-Jazi M, et al. Sex-specific association of FABP2 polymorphisms with the risk of obesity in the Tehran Cardio-Metabolic Genetic Study (TCGS). Gene. 2023;876:. https:\/\/doi.org\/10.1016\/j.gene.2023.147519.","DOI":"10.1016\/j.gene.2023.147519"},{"key":"6049_CR22","doi-asserted-by":"publisher","unstructured":"Martin AR, Kanai M, Kamatani Y, et al. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet. 2019;51:584\u2013591. https:\/\/doi.org\/10.1038\/s41588-019-0379-x.","DOI":"10.1038\/s41588-019-0379-x"},{"key":"6049_CR23","doi-asserted-by":"publisher","unstructured":"Duncan L, Shen H, Gelaye B, et al. Analysis of polygenic risk score usage and performance in diverse human populations. Nat Commun. 2019;10:. https:\/\/doi.org\/10.1038\/s41467-019-11112-0.","DOI":"10.1038\/s41467-019-11112-0"},{"key":"6049_CR24","doi-asserted-by":"publisher","unstructured":"Martin AR, Gignoux CR, Walters RK, et al. Human Demographic History Impacts Genetic Risk Prediction across Diverse Populations. Am J Hum Genet. 2017;100:635\u2013649. https:\/\/doi.org\/10.1016\/j.ajhg.2017.03.004.","DOI":"10.1016\/j.ajhg.2017.03.004"},{"key":"6049_CR25","doi-asserted-by":"publisher","unstructured":"Liu LY, Schaub MA, Sirota M, Butte AJ. Sex differences in disease risk from reported genome-wide association study findings. Hum Genet. 2012;131:353\u2013364. https:\/\/doi.org\/10.1007\/s00439-011-1081-y.","DOI":"10.1007\/s00439-011-1081-y"},{"key":"6049_CR26","doi-asserted-by":"publisher","unstructured":"Orozco G, Ioannidis JPA, Morris A, Zeggini E. Sex-specific differences in effect size estimates at established complex trait loci. Int J Epidemiol. 2012;41:1376\u20131382. https:\/\/doi.org\/10.1093\/ije\/dys104.","DOI":"10.1093\/ije\/dys104"},{"key":"6049_CR27","doi-asserted-by":"publisher","unstructured":"Daneshpour MS, Akbarzadeh M, Lanjanian H, et al. Cohort profile update: Tehran cardiometabolic genetic study. Eur J Epidemiol. 2023;38:699\u2013711. https:\/\/doi.org\/10.1007\/s10654-023-01008-1.","DOI":"10.1007\/s10654-023-01008-1"},{"key":"6049_CR28","doi-asserted-by":"publisher","unstructured":"Azizi F, Ghanbarian A, Momenan AA, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009;10:5. https:\/\/doi.org\/10.1186\/1745-6215-10-5.","DOI":"10.1186\/1745-6215-10-5"},{"key":"6049_CR29","doi-asserted-by":"crossref","unstructured":"Moazzeni SS, Ghafelehbashi H, Hasheminia M, et al. Sex-specific prevalence of coronary heart disease among Tehranian adult population across different glycemic status: Tehran lipid and glucose study, 2008\u20132011. BMC Public Health. 2020;20:1510","DOI":"10.1186\/s12889-020-09595-4"},{"key":"6049_CR30","doi-asserted-by":"publisher","unstructured":"Daneshpour MS, Fallah M-S, Sedaghati-Khayat B, et al. Rationale and Design of a Genetic Study on Cardiometabolic Risk Factors: Protocol for the Tehran Cardiometabolic Genetic Study (TCGS). JMIR Res Protoc. 2017;6:e28. https:\/\/doi.org\/10.2196\/resprot.6050.","DOI":"10.2196\/resprot.6050"},{"key":"6049_CR31","doi-asserted-by":"publisher","unstructured":"J\u00f3nsson H, Sulem P, Kehr B, et al. Data Descriptor: Whole genome characterization of sequence diversity of 15,220 Icelanders. Sci Data. 2017;4:1\u20139. https:\/\/doi.org\/10.1038\/sdata.2017.115.","DOI":"10.1038\/sdata.2017.115"},{"key":"6049_CR32","doi-asserted-by":"publisher","unstructured":"Iribarren C, Lu M, Jorgenson E, et al. Weighted Multi-marker Genetic Risk Scores for Incident Coronary Heart Disease among Individuals of African, Latino and East-Asian Ancestry. Sci Rep. 2018;8:1\u201313. https:\/\/doi.org\/10.1038\/s41598-018-25128-x.","DOI":"10.1038\/s41598-018-25128-x"},{"key":"6049_CR33","doi-asserted-by":"publisher","unstructured":"Rinc\u00f3n LM, Subirana I, P\u00e9rez del Villar C, et al. Predictive capacity of a genetic risk score for coronary artery disease in assessing recurrences and cardiovascular mortality among patients with myocardial infarction. Front Cardiovasc Med. 2023;10:. https:\/\/doi.org\/10.3389\/fcvm.2023.1254066.","DOI":"10.3389\/fcvm.2023.1254066"},{"key":"6049_CR34","doi-asserted-by":"publisher","unstructured":"Rinc\u00f3n LM, Sanmart\u00edn M, Alonso GL, et al. A genetic risk score predicts recurrent events after myocardial infarction in young adults. Rev Espa\u00f1ola Cardiol (English Ed). 2020;73:623\u2013631. https:\/\/doi.org\/10.1016\/j.rec.2019.08.006.","DOI":"10.1016\/j.rec.2019.08.006"},{"key":"6049_CR35","doi-asserted-by":"publisher","unstructured":"Lluis-Ganella C, Subirana I, Lucas G, et al. Assessment of the value of a genetic risk score in improving the estimation of coronary risk. Atherosclerosis. 2012;222:456\u2013463. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2012.03.024.","DOI":"10.1016\/j.atherosclerosis.2012.03.024"},{"key":"6049_CR36","doi-asserted-by":"publisher","unstructured":"Koyama S, Ito K, Terao C, et al. Population-specific and trans-ancestry genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease. Nat Genet. 2020;52:1169\u20131177. https:\/\/doi.org\/10.1038\/s41588-020-0705-3.","DOI":"10.1038\/s41588-020-0705-3"},{"key":"6049_CR37","doi-asserted-by":"publisher","unstructured":"Uno H, Cai T, Pencina MJ, et al. On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat Med. 2011;30:1105\u20131117. https:\/\/doi.org\/10.1002\/sim.4154.","DOI":"10.1002\/sim.4154"},{"key":"6049_CR38","doi-asserted-by":"crossref","unstructured":"Caetano SJ, Sonpavde G, Pond GR. C-statistic: A brief explanation of its construction, interpretation and limitations. Eur. J. Cancer. 2018;90:130\u2013132","DOI":"10.1016\/j.ejca.2017.10.027"},{"key":"6049_CR39","doi-asserted-by":"publisher","unstructured":"Pencina MJ, D\u2019Agostino RB, D\u2019Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157\u2013172. https:\/\/doi.org\/10.1002\/sim.2929.","DOI":"10.1002\/sim.2929"},{"key":"6049_CR40","doi-asserted-by":"publisher","unstructured":"Pencina MJ, D\u2019Agostino RB, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11\u201321. https:\/\/doi.org\/10.1002\/sim.4085.","DOI":"10.1002\/sim.4085"},{"key":"6049_CR41","doi-asserted-by":"publisher","unstructured":"Mars N, Koskela JT, Ripatti P, et al. Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers. Nat Med. 2020;26:549\u2013557. https:\/\/doi.org\/10.1038\/s41591-020-0800-0.","DOI":"10.1038\/s41591-020-0800-0"},{"key":"6049_CR42","doi-asserted-by":"publisher","unstructured":"Yang ML, Xu C, Gupte T, Hoffmann TJ, Iribarren C, Zhou X, Ganesh SK. Sex-specific genetic architecture of blood pressure. Nature medicine. 2024.30(3):818\u2009\u2212\u200928. https:\/\/doi.org\/10.1038\/s41591-024-02858-2.","DOI":"10.1038\/s41591-024-02858-2"},{"key":"6049_CR43","doi-asserted-by":"crossref","unstructured":"Abraham G, Rutten-Jacobs L, Inouye M. Risk Prediction Using Polygenic Risk Scores for Prevention of Stroke and Other Cardiovascular Diseases. Stroke. 2021;52:2983\u20132991","DOI":"10.1161\/STROKEAHA.120.032619"},{"key":"6049_CR44","doi-asserted-by":"publisher","unstructured":"Murthy VL, Xia R, Baldridge AS, et al. Polygenic Risk, Fitness, and Obesity in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. JAMA Cardiol. 2020;5:263. https:\/\/doi.org\/10.1001\/jamacardio.2019.5220.","DOI":"10.1001\/jamacardio.2019.5220"},{"key":"6049_CR45","doi-asserted-by":"crossref","unstructured":"Kuznetsova T. Sex differences in epidemiology of cardiac and vascular disease. In: Advances in Experimental Medicine and Biology. Springer New York LLC. 2018.pp 61\u201370","DOI":"10.1007\/978-3-319-77932-4_4"},{"key":"6049_CR46","doi-asserted-by":"publisher","unstructured":"\u00d8vretveit K, Ingestr\u00f6m EML, Spitieris M, et al. Polygenic risk scores associate with blood pressure traits across the lifespan. Eur J Prev Cardiol. 2024;31:644\u2013654. https:\/\/doi.org\/10.1093\/eurjpc\/zwad365.","DOI":"10.1093\/eurjpc\/zwad365"},{"key":"6049_CR47","doi-asserted-by":"publisher","unstructured":"Song Y, Choi JE, Kwon YJ, et al. Identification of susceptibility loci for cardiovascular disease in adults with hypertension, diabetes, and dyslipidemia. J Transl Med. 2021;19:85. https:\/\/doi.org\/10.1186\/s12967-021-02751-3.","DOI":"10.1186\/s12967-021-02751-3"},{"key":"6049_CR48","doi-asserted-by":"crossref","unstructured":"Benes LB, Brandt DJ, Brandt EJ, Davidson MH. How Genomics Is Personalizing the Management of Dyslipidemia and Cardiovascular Disease Prevention. Curr. Cardiol. Rep. 2018;20:138","DOI":"10.1007\/s11886-018-1079-3"},{"key":"6049_CR49","doi-asserted-by":"publisher","unstructured":"Parcha V, Pampana A, Shetty NS, et al. Association of a Multiancestry Genome-Wide Blood Pressure Polygenic Risk Score with Adverse Cardiovascular Events. Circ Genomic Precis Med. 2022;15:E003946. https:\/\/doi.org\/10.1161\/CIRCGEN.122.003946.","DOI":"10.1161\/CIRCGEN.122.003946"},{"key":"6049_CR50","doi-asserted-by":"publisher","unstructured":"Howe LD, Parmar PG, Paternoster L, et al. Genetic influences on trajectories of systolic blood pressure across childhood and adolescence. Circ Cardiovasc Genet. 2013;6:608\u2013614. https:\/\/doi.org\/10.1161\/CIRCGENETICS.113.000197.","DOI":"10.1161\/CIRCGENETICS.113.000197"},{"key":"6049_CR51","doi-asserted-by":"publisher","unstructured":"Theodore RF, Broadbent J, Nagin D, et al. Childhood to Early-Midlife Systolic Blood Pressure Trajectories: Early-Life Predictors, Effect Modifiers, and Adult Cardiovascular Outcomes. Hypertension. 2015;66:1108\u20131115. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.05831.","DOI":"10.1161\/HYPERTENSIONAHA.115.05831"},{"key":"6049_CR52","doi-asserted-by":"publisher","unstructured":"Shen W, Zhang T, Li S, et al. Race and Sex Differences of Long-Term Blood Pressure Profiles from Childhood and Adult Hypertension: The Bogalusa Heart Study. Hypertension. 2017;70:66\u201374. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.09537.","DOI":"10.1161\/HYPERTENSIONAHA.117.09537"},{"key":"6049_CR53","doi-asserted-by":"publisher","unstructured":"Tam CHT, Lim CKP, Luk AOY, et al. Development of genome-wide polygenic risk scores for lipid traits and clinical applications for dyslipidemia, subclinical atherosclerosis, and diabetes cardiovascular complications among East Asians. Genome Med. 2021;13:29. https:\/\/doi.org\/10.1186\/s13073-021-00831-z.","DOI":"10.1186\/s13073-021-00831-z"},{"key":"6049_CR54","doi-asserted-by":"publisher","unstructured":"Ye Y, Chen X, Han J, et al. Interactions Between Enhanced Polygenic Risk Scores and Lifestyle for Cardiovascular Disease, Diabetes, and Lipid Levels. Circ Genomic Precis Med. 2021;14:E003128. https:\/\/doi.org\/10.1161\/CIRCGEN.120.003128.","DOI":"10.1161\/CIRCGEN.120.003128"},{"key":"6049_CR55","doi-asserted-by":"crossref","unstructured":"Grundy SM, Cleeman JI, Bairey Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227\u2013239","DOI":"10.1161\/01.CIR.0000133317.49796.0E"},{"key":"6049_CR56","unstructured":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/12485966\/ Accessed 22 Nov 2025."},{"key":"6049_CR57","doi-asserted-by":"publisher","unstructured":"Ram\u00edrez J, Van Duijvenboden S, Young WJ, et al. Prediction of Coronary Artery Disease and Major Adverse Cardiovascular Events Using Clinical and Genetic Risk Scores for Cardiovascular Risk Factors. Circ Genomic Precis Med. 2022;15:444\u2013452. https:\/\/doi.org\/10.1161\/CIRCGEN.121.003441.","DOI":"10.1161\/CIRCGEN.121.003441"},{"key":"6049_CR58","doi-asserted-by":"publisher","unstructured":"Yun H, Lim JE, Lee EY. Genetic Risk Score for Prediction of Coronary Heart Disease in the Korean Genome and Epidemiology Study. Rev Cardiovasc Med. 2023;24:. https:\/\/doi.org\/10.31083\/j.rcm2404102.","DOI":"10.31083\/j.rcm2404102"},{"key":"6049_CR59","doi-asserted-by":"publisher","unstructured":"Lu X, Niu X, Shen C, et al. Development and Validation of a Polygenic Risk Score for Stroke in the Chinese Population. Neurology. 2021;97:E619\u2013E628. https:\/\/doi.org\/10.1212\/WNL.0000000000012263.","DOI":"10.1212\/WNL.0000000000012263"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06049-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06049-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06049-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:06:05Z","timestamp":1783569965000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06049-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6049"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06049-4","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"17 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee approved all procedures conducted in this human research study at the Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences (code: IR.SBMU.ENDOCRINE.REC.1402.107), which adhered to the 1964 Helsinki Declaration and its subsequent amendments, or comparable ethical standards.Written informed consent to participate was obtained from all participants prior to their inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"587"}}